Norman J. Lacayo, MD
Clinical Trials
- Not Recruiting Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
- Recruiting Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
- Recruiting A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
- Not Recruiting A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
- Not Recruiting Ixabepilone in Treating Young Patients With Refractory Solid Tumors
- Not Recruiting Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
- Not Recruiting Sorafenib (BAY 43-9006) to Treat Children With Solid Tumors or Leukemias
Help